FdaApplication
NDA 212028
Identifiers
- fda_app_no: NDA212028
Properties
| Property | Value |
|---|---|
| applicant_name | EISAI INC |
| application_type | NDA |
| approval_date | 2020-04-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAYVIGO | LEMBOREXANT | 10MG | TABLET;ORAL |
| DAYVIGO | LEMBOREXANT | 5MG | TABLET;ORAL |
2 products